August Is Hot with New FDA Breakthrough Device Designations
V-Wave is joining the growing list of companies that have been granted breakthrough device designation by FDA this month. The Caesarea, Israel-based company gained the designation for its interatrial shunt for heart failure.
Miniature and minimally invasive, the interatrial shunt relieves increased left atrial pressure, which in turn, decreases fluid build-up in the lungs.
“The interatrial shunt allows a small amount of blood volume from the left side of the heart to flow into the right side of the heart,†Murtaza Mogri, PhD Director, Business Development & Market Access V-Wave, tol...
Source: MDDI - August 16, 2019 Category: Medical Devices Authors: Omar Ford Tags: Cardiovascular Business Source Type: news
Siemens Set to Jump into Robotics with Proposed Acquisition of Corindus
It looks like Siemens Healthineers is keen on diving into the medical robotics space. The Erlangen, Germany-based company said its subsidiary Siemens Medical Solutions is set to acquire Corindus Vascular Robotics for about $4.28 per share in cash or$1.1 billion.
The transaction has been approved by Corindus’ board and is expected to close in 4Q19, subject to approval by the company’s stockholders.
“Corindus has established a leading position in vascular robotics with a compelling technology platform for robotic-assisted coronary, peripheral, and neurovascular procedures...
Source: MDDI - August 8, 2019 Category: Medical Devices Authors: Omar Ford Tags: Imaging Source Type: news
Machine learning better predicts bleeding risk during coronary procedures
Machine learning techniques can better predict bleeding for patients undergoing percutaneous coronary intervention than other methods, report Yale researchers. (Source: Yale Science and Health News)
Source: Yale Science and Health News - July 22, 2019 Category: Universities & Medical Training Source Type: news
New Port Richey medical center performs first robotic-assisted procedure for arteries
The Medical Center of Trinity has successfully performed its first robotic-assisted angioplasty, which is the first for Tampa Bay and the first on Florida ’s west coast.
The robotic tools help the physicians treat patients with coronary artery disease.
Coronary artery disease, the plaque buildup that restricts blood flow in the arteries, is a widespread and life-threatening condition. Traditionally, percutaneous coronary intervention commonly kno wn as an ‘angioplasty,’ is the most common… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - July 3, 2019 Category: American Health Authors: Veronica Brezina-Smith Source Type: news
New Port Richey medical center performs first robotic-assisted procedure for arteries
The Medical Center of Trinity has successfully performed its first robotic-assisted angioplasty, which is the first for Tampa Bay and the first on Florida ’s west coast.
The robotic tools help the physicians treat patients with coronary artery disease.
Coronary artery disease, the plaque buildup that restricts blood flow in the arteries, is a widespread and life-threatening condition. Traditionally, percutaneous coronary intervention commonly kno wn as an ‘angioplasty,’ is the most common… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - July 3, 2019 Category: Biotechnology Authors: Veronica Brezina-Smith Source Type: news
Cardiac Arrest, Death During Elective PCI Concerningly Common Cardiac Arrest, Death During Elective PCI Concerningly Common
A European registry puts mortality at only about 50% if a patient arrests on the table during an elective percutaneous coronary intervention.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - June 4, 2019 Category: Cardiology Tags: Cardiology News Source Type: news
Open Heart Surgery Beats Stents for Multivessel Disease
FRIDAY, May 17, 2019 -- Coronary artery bypass graft (CABG) surgery may be a better treatment option than percutaneous coronary intervention (PCI) for most patients with more than one blocked heart artery, according to a study published online May 1... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 17, 2019 Category: Pharmaceuticals Source Type: news
Corindus Misses Expectations, But Still Embraced by Wall Street
Corindus Vascular Robotics missed earnings per share expectations by one cent, but Wall Street didn’t seem to mind as shares of the medtech company, which was a 2015 MDEA finalist, soared on Wednesday.
At one-point shares were up by as much as 23%.
The surgical robotics maker reported 1Q19 EPS of $0.05 against the analyst estimate of $0.04. Revenue for 1Q19 was $3 million vs. the consensus estimate of $3.11 million. The Waltham, MA-based company recorded purchase orders for 11 CorPath GRX Systems, an increase of 83% compared to purchase orders received in 4Q18 and 267% growth compared to the purchase orde...
Source: MDDI - May 8, 2019 Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news
PCI Beneficial for All Categories of Older AMI Patients
WEDNESDAY, April 24, 2019 -- For older patients with acute myocardial infarction (AMI), percutaneous coronary intervention (PCI) is beneficial across age strata, according to a research letter published online April 23 in Circulation: Cardiovascular... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 24, 2019 Category: Pharmaceuticals Source Type: news
Non-Adherence to Antiplatelet Therapy After PCI Ups Risk of MACE in Anemic Patients Non-Adherence to Antiplatelet Therapy After PCI Ups Risk of MACE in Anemic Patients
In anemic patients who have undergone percutaneous coronary intervention (PCI), non-adherence to dual antiplatelet therapy (DAPT) - but not physician-recommended discontinuation - is associated with a higher risk of major adverse cardiovascular events (MACE) in the two years following the procedure, researchers say.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 23, 2019 Category: Consumer Health News Tags: Cardiology News Source Type: news
Seniors Less Likely to Receive or Have Timely PCI for Acute MI
MONDAY, April 8, 2019 -- Seniors with acute myocardial infarction (AMI) are less likely to undergo percutaneous coronary intervention (PCI) or receive PCI in a timely manner, according to a study presented at the American Heart Association Quality... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 8, 2019 Category: Pharmaceuticals Source Type: news
Meet the Robot That Can Help Perform Angioplasty
There's a new surgical robot on the market in Europe and the Middle East, and this one can assist in stenting procedures such as angioplasty. Rouen, France-based Robocath developed R-One, which is the first European robotic solution to obtain the CE mark in the field of interventional cardiology.
R-One is designed to enable precision technologies that complement existing methods, in order to improve procedures and the working environment. The company said the device uses a unique technology that optimizes the safety of robotic-assisted coronary angioplasty. The R-One has an open architecture so it i...
Source: MDDI - March 18, 2019 Category: Medical Devices Authors: Amanda Pedersen Tags: Cardiovascular Source Type: news
Radial, femoral access for PCI found equal in terms of survival
(American College of Cardiology) Doctors can use either an artery in the arm (the radial approach) or in the groin (the femoral approach) to safely perform percutaneous coronary intervention (PCI) on patients presenting with a heart attack, according to research presented at the American College of Cardiology's 68th Annual Scientific Session. The research, which was stopped early, suggests the radial and femoral approach are equivalent in terms of the risk of death at 30 days. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 18, 2019 Category: International Medicine & Public Health Source Type: news
CRF research to be presented at ACC.19
(Cardiovascular Research Foundation) Research from the Cardiovascular Research Foundation and the CRF Clinical Trials Center will be presented at the American College of Cardiology's 68th Annual Scientific Session taking place March 16-18, 2019 at the Ernest N. Morial Convention Center in New Orleans, Louisiana. They will be presenting the latest data on percutaneous coronary intervention (PCI), imaging technologies, renal denervation, and transcatheter aortic valve replacement. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 14, 2019 Category: International Medicine & Public Health Source Type: news
PCI in Stable Coronary Artery Disease: Still in Equipoise? PCI in Stable Coronary Artery Disease: Still in Equipoise?
The benefits of percutaneous coronary intervention remain controversial in patients with stable coronary artery disease. What insights does a recent study add?European Heart Journal (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 11, 2019 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news
